Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 31.24
(-0.13%)
CNY 31.24
(-0.13%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 743.33 Million CNY | 29.71% |
| 2022 | 573.08 Million CNY | 18.5% |
| 2021 | 483.6 Million CNY | 11.02% |
| 2020 | 435.6 Million CNY | 50.4% |
| 2019 | 289.63 Million CNY | 39.58% |
| 2018 | 207.5 Million CNY | 41.45% |
| 2017 | 146.69 Million CNY | 12.48% |
| 2016 | 130.42 Million CNY | 200.42% |
| 2015 | 43.41 Million CNY | -45.63% |
| 2014 | 79.84 Million CNY | -7.42% |
| 2013 | 86.24 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 741.2 Million CNY | -8.27% |
| 2024 Q1 | 748.26 Million CNY | 0.66% |
| 2024 Q2 | 808.07 Million CNY | 7.99% |
| 2023 Q2 | 575.82 Million CNY | -2.89% |
| 2023 FY | 743.33 Million CNY | 29.71% |
| 2023 Q3 | 644.3 Million CNY | 11.89% |
| 2023 Q1 | 592.97 Million CNY | 3.47% |
| 2023 Q4 | 743.33 Million CNY | 15.37% |
| 2022 Q2 | 569.71 Million CNY | 10.42% |
| 2022 Q1 | 515.96 Million CNY | 6.69% |
| 2022 FY | 573.08 Million CNY | 18.5% |
| 2022 Q4 | 573.08 Million CNY | -6.04% |
| 2022 Q3 | 609.93 Million CNY | 7.06% |
| 2021 FY | 483.6 Million CNY | 11.02% |
| 2021 Q4 | 483.6 Million CNY | -2.08% |
| 2021 Q1 | 417.23 Million CNY | -4.22% |
| 2021 Q2 | 403.19 Million CNY | -3.36% |
| 2021 Q3 | 493.88 Million CNY | 22.49% |
| 2020 Q2 | 316.01 Million CNY | 33.51% |
| 2020 FY | 435.6 Million CNY | 50.4% |
| 2020 Q3 | 362.75 Million CNY | 14.79% |
| 2020 Q4 | 435.6 Million CNY | 20.09% |
| 2020 Q1 | 236.7 Million CNY | -18.27% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 289.63 Million CNY | 39.58% |
| 2019 Q4 | 289.63 Million CNY | 0.0% |
| 2018 FY | 207.5 Million CNY | 41.45% |
| 2017 FY | 146.69 Million CNY | 12.48% |
| 2016 Q2 | 59.12 Million CNY | 0.0% |
| 2016 Q1 | 59.12 Million CNY | 36.18% |
| 2016 FY | 130.42 Million CNY | 200.42% |
| 2015 Q4 | 43.41 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 43.41 Million CNY | -45.63% |
| 2014 FY | 79.84 Million CNY | -7.42% |
| 2013 FY | 86.24 Million CNY | 0.0% |